Neofordex - direct healthcare professional communication (DHPC)

dexamethasone

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Neofordex 40 mg (dexamethasone): removal of the score-line and the associated 20 mg posology

Dissemination date: 17/02/2023

Key facts

• Medicine name:
  Neofordex
• Active substance:
  dexamethasone
• Therapeutic area (MeSH):
  Multiple Myeloma
• Procedure number:
  EMEA/H/C/004071/II/0017-G
• Regulatory outcome:
  Variation
• DHPC type:
  Change in dosing recommendation
• Human ATC codes:
  H02AB02
• Dissemination date:
  17/02/2023